<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02878850</url>
  </required_header>
  <id_info>
    <org_study_id>TEMPLE - 001</org_study_id>
    <nct_id>NCT02878850</nct_id>
  </id_info>
  <brief_title>Randomized Trial of Early Hemodynamic Management of Patients Following Acute Spinal Cord Injury</brief_title>
  <acronym>TEMPLE</acronym>
  <official_title>Randomized Trial of Early Hemodynamic Management of Patients Following Acute Spinal Cord Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>United States Department of Defense</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn more about how participants heal from acute spinal cord
      injury.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, the investigators will learn about the effect of targeted blood pressure
      management (TPM) on participants healing from acute spinal cord injury.

      The investigators want to learn:

      The effect of two types of TPM on long term motor and sensory outcomes. The effect of two
      types of TPM on long-term pain and functional independence outcomes.

      How safe TPM is for participants.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 10, 2017</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in motor and sensory American Spinal Injury Association (ASIA) scores.</measure>
    <time_frame>6 months after spinal cord injury</time_frame>
    <description>Change from baseline in long-term motor and sensory scores, comparing patients maintained at a MAP target between 65 and 70 mm Hg, and patients maintained at a MAP target between 85 and 90 mm Hg for a duration of seven days or until ICU discharge.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spinal Cord Independence Measure III score</measure>
    <time_frame>6 months after spinal cord injury</time_frame>
    <description>Spinal Cord Independence Measure III (Total Score, no units)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain scores on the International Spinal Cord Injury Basic Pain Data Set</measure>
    <time_frame>6 months after spinal cord injury</time_frame>
    <description>Pain scores on the International Spinal Cord Injury Basic Pain Data Set (Pain Interference Score; range 0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>6 months after spinal cord injury</time_frame>
    <description>Quality of Life (Life Satisfaction Score; range 0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular Function</measure>
    <time_frame>6 months after spinal cord injury</time_frame>
    <description>Cardiovascular Function (Event occurrence)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of respiratory complications</measure>
    <time_frame>7 days after randomization or ICU discharge</time_frame>
    <description>Number of respiratory complications (Event frequency)</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of cardiac complications</measure>
    <time_frame>7 days after randomization or ICU discharge</time_frame>
    <description>Number of cardiac complications (Event frequency)</description>
  </other_outcome>
  <other_outcome>
    <measure>Sequential Multiple Organ Failure score (SOFA)</measure>
    <time_frame>7 days after randomization or ICU discharge</time_frame>
    <description>Sequential Multiple Organ Failure score (SOFA) (Total Score, no units)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">152</enrollment>
  <condition>Spinal Cord Injury</condition>
  <arm_group>
    <arm_group_label>Augmented Blood Pressure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will have their blood pressure kept in a higher range.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Blood Pressure</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will have their blood pressure kept in a normal range.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Augmented Blood Pressure</intervention_name>
    <description>Subjects will have their blood pressure kept in a higher range.</description>
    <arm_group_label>Augmented Blood Pressure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Acute traumatic spinal cord injury (SCI) involving neurological levels as defined by
             the ASIA neurological examination between C0 and T8 (tetraplegia) and resulting in new
             onset neurological deficits consistent with an ASIA motor assessment of level A, B or
             C.

          2. Subject is 18 years of age or older.

        Exclusion Criteria:

          1. Penetrating SCI injury.

          2. Isolated cauda equina syndrome or injury at bony level Th9 or below.

          3. Pre-existing motor deficit secondary to chronic myelopathy.

          4. History of demyelinating disease or central nervous system autoimmune disorder.

          5. History within the past six months and/or physical findings on admission of
             decompensated congestive heart failure (NYHA functional class III or IV, or objective
             class C or D).

          6. Acute, evolving or recent (30 days) myocardial infarction.

          7. Chronic renal failure requiring dialysis.

          8. Suspected or confirmed pregnancy.

          9. Severe terminal disease with life expectancy less than 6 months.

         10. Severe traumatic brain injury at presentation (GCS ≤8) with confirmation of injury on
             brain imaging.

         11. A condition that would preclude the performance of an accurate neurological exam due
             to a prior diagnosis of Alzheimer's disease, stroke, degenerative condition, cerebral
             tumor, or mental retardation.

         12. Non-English or Non-Spanish Speaking.

         13. Refusal of consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miriam Treggiari, MD, PhD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Kampp, BS, CCRP</last_name>
    <phone>203-737-5118</phone>
    <email>michael.kampp@yale.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laura Sissons-Ross, AS</last_name>
    <phone>503-494-9545</phone>
    <email>sissonsr@ohsu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clare Binley, RN, CCRP</last_name>
      <phone>323-409-1532</phone>
      <email>Clare.Binley@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Roy Poblete, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06511</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Penn-Touré, B.A., CAPM</last_name>
      <phone>913-588-0068</phone>
      <email>jtoure@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Winfield, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania Health System</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joy Steele</last_name>
      <phone>215-662-9423</phone>
      <email>Joy.Steele@pennmedicine.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Niels Martin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allegra Bermudez</last_name>
      <phone>215-955-9973</phone>
      <email>Allegra.Bermudez@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Anirudh Kohli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janice Alicandro</last_name>
      <phone>412-864-2188</phone>
      <email>alicandroja@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>David Okonkwo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>August 3, 2016</study_first_submitted>
  <study_first_submitted_qc>August 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2016</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Miriam Treggiari</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

